UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microtubule Active Agents: Beyond the Taxane Frontier

Clinical cancer research, 2008-11, Vol.14 (22), p.7167-7172

2008

Volltextzugriff (PDF)

NCCN Task Force Report: Bone Health In Cancer Care

Journal of the National Comprehensive Cancer Network, 2013-08, Vol.11 Suppl 3 (suppl 3), p.S1-S-50

2013

Volltextzugriff (PDF)

Long-term Clinical Outcomes of Whole-Breast Irradiation Delivered in the Prone Position

International journal of radiation oncology, biology, physics, 2007-05, Vol.68 (1), p.73-81

2007

Volltextzugriff (PDF)

Denosumab: second chapter in controlling bone metastases or a new book?

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5127-5131

Fornier, Monica N

2010

Volltextzugriff (PDF)

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2587-2595

2001

Volltextzugriff (PDF)

Locoregional Outcomes of Inflammatory Breast Cancer Patients Treated With Standard Fractionation Radiation and Daily Skin Bolus in the Taxane Era

International journal of radiation oncology, biology, physics, 2010-07, Vol.77 (4), p.1105-1112

2010

Volltextzugriff (PDF)

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score

Journal of bone oncology, 2017-06, Vol.7 (C), p.32-37

2017

Volltextzugriff (PDF)

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer

Clinical cancer research, 2021-07, Vol.27 (14), p.3867-3875

2021

Volltextzugriff (PDF)

Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases

Journal of oral and maxillofacial surgery, 2012-12, Vol.70 (12), p.2768-2775

2012

Volltextzugriff (PDF)

Oral minoxidil for late alopecia in cancer survivors

Breast cancer research and treatment, 2024-12, Vol.208 (3), p.491-499

2024

Volltextzugriff (PDF)

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Clinical breast cancer, 2018-10, Vol.18 (5), p.387-394

2018

Volltextzugriff (PDF)

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.307-315

2021

Volltextzugriff (PDF)

Approved Agents for Metastatic Breast Cancer

Seminars in oncology, 2011-06, Vol.38, p.S3-S10

Fornier, Monica N

2011

Volltextzugriff (PDF)

Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

Cancer, 2005-10, Vol.104 (8), p.1575-1579

2005

Volltextzugriff (PDF)

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy

Annals of translational medicine, 2020-12, Vol.8 (24), p.1694-1694

2020

Volltextzugriff (PDF)

NCCN Task Force Report: Bone Health in Cancer Care

Journal of the National Comprehensive Cancer Network, 2009-06, Vol.7 Suppl 3 (Suppl_3), p.S1-S-32

2009

Volltextzugriff (PDF)

Less Intense Dosing Schedule for a Bone-Modifying Agent

JAMA oncology, 2017-07, Vol.3 (7), p.893

Fornier, Monica N

2017

Volltextzugriff (PDF)

Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer

Cancer prevention research (Philadelphia, Pa.), 2013-05, Vol.6 (5), p.428-436

2013

Volltextzugriff (PDF)

Increased Dose Density Is Feasible: A Pilot Study of Adjuvant Epirubicin and Cyclophosphamide followed by Paclitaxel, at 10- or 11-Day Intervals with Filgrastim Support in Women with Breast Cancer

Clinical cancer research, 2007-01, Vol.13 (1), p.223-227

2007

Volltextzugriff (PDF)

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

Supportive care in cancer, 2012-11, Vol.20 (11), p.2661-2668

2012

Volltextzugriff (PDF)

Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer

Clinical breast cancer, 2014-12, Vol.14 (6), p.e111-e111

2014

Volltextzugriff (PDF)

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial

JAMA network open, 2019-11, Vol.2 (11), p.e1916211-e1916211

2019

Volltextzugriff (PDF)

Ixabepilone, First in a New Class of Antineoplastic Agents: The Natural Epothilones and Their Analogues

Clinical breast cancer, 2007-10, Vol.7 (10), p.9-15

Fornier, Monica N

2007

Volltextzugriff (PDF)

Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer

The breast journal, 2012-07, Vol.18 (4), p.345-350

2012

Volltextzugriff (PDF)

Novel anti-tubulin cytotoxic agents for breast cancer

Expert review of anticancer therapy, 2009-02, Vol.9 (2), p.175-185

2009

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Oncology
(34)
Humans
(30)
Female
(27)
Breast Neoplasms - Drug Therapy
(20)
Adult
(16)
Middle Aged
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Aged
(14)
Breast Neoplasms - Pathology
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Breast Cancer
(12)
Hematology, Oncology And Palliative Medicine
(11)
Tumors
(10)
Pharmacology. Drug Treatments
(9)
Antineoplastic Agents
(8)
Antineoplastic Agents - Therapeutic Use
(8)
Chemotherapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Microtubule Active Agents: Beyond the Taxane Frontier

NCCN Task Force Report: Bone Health In Cancer Care

Long-term Clinical Outcomes of Whole-Breast Irradiation Delivered in the Prone Position

Denosumab: second chapter in controlling bone metastases or a new book?

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification

Locoregional Outcomes of Inflammatory Breast Cancer Patients Treated With Standard Fractionation Radiation and Daily Skin Bolus in the Taxane Era

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score

A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA -Mutated HER2-Positive Metastatic Breast Cancer

Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases

Oral minoxidil for late alopecia in cancer survivors

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy?

Approved Agents for Metastatic Breast Cancer

Incidence of chemotherapy‐induced, long‐term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy

NCCN Task Force Report: Bone Health in Cancer Care

Less Intense Dosing Schedule for a Bone-Modifying Agent

Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer

Increased Dose Density Is Feasible: A Pilot Study of Adjuvant Epirubicin and Cyclophosphamide followed by Paclitaxel, at 10- or 11-Day Intervals with Filgrastim Support in Women with Breast Cancer

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial

Ixabepilone, First in a New Class of Antineoplastic Agents: The Natural Epothilones and Their Analogues

Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer

Novel anti-tubulin cytotoxic agents for breast cancer

Suchergebnisse filtern